These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
227 related items for PubMed ID: 17564582
1. The EWS-Oct-4 fusion gene encodes a transforming gene. Lee J, Kim JY, Kang IY, Kim HK, Han YM, Kim J. Biochem J; 2007 Sep 15; 406(3):519-26. PubMed ID: 17564582 [Abstract] [Full Text] [Related]
3. Stimulation of Oct-4 activity by Ewing's sarcoma protein. Lee J, Rhee BK, Bae GY, Han YM, Kim J. Stem Cells; 2005 Sep 15; 23(6):738-51. PubMed ID: 15917470 [Abstract] [Full Text] [Related]
4. The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour. Lee SB, Kolquist KA, Nichols K, Englert C, Maheswaran S, Ladanyi M, Gerald WL, Haber DA. Nat Genet; 1997 Nov 15; 17(3):309-13. PubMed ID: 9354795 [Abstract] [Full Text] [Related]
5. Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene. Lessnick SL, Braun BS, Denny CT, May WA. Oncogene; 1995 Feb 02; 10(3):423-31. PubMed ID: 7845667 [Abstract] [Full Text] [Related]
6. The EWS/TEC fusion protein encoded by the t(9;22) chromosomal translocation in human chondrosarcomas is a highly potent transcriptional activator. Labelle Y, Bussières J, Courjal F, Goldring MB. Oncogene; 1999 May 27; 18(21):3303-8. PubMed ID: 10359536 [Abstract] [Full Text] [Related]
7. The desmoplastic small round cell tumor t(11;22) translocation produces EWS/WT1 isoforms with differing oncogenic properties. Kim J, Lee K, Pelletier J. Oncogene; 1998 Apr 16; 16(15):1973-9. PubMed ID: 9591781 [Abstract] [Full Text] [Related]
8. The DNA binding domains of the WT1 tumor suppressor gene product and chimeric EWS/WT1 oncoprotein are functionally distinct. Kim J, Lee K, Pelletier J. Oncogene; 1998 Feb 26; 16(8):1021-30. PubMed ID: 9519876 [Abstract] [Full Text] [Related]
9. The EWS-ATF-1 gene involved in malignant melanoma of soft parts with t(12;22) chromosome translocation, encodes a constitutive transcriptional activator. Fujimura Y, Ohno T, Siddique H, Lee L, Rao VN, Reddy ES. Oncogene; 1996 Jan 04; 12(1):159-67. PubMed ID: 8552387 [Abstract] [Full Text] [Related]
10. Critical role of the fibroblast growth factor signalling pathway in Ewing's sarcoma octamer-binding transcription factor 4-mediated cell proliferation and tumorigenesis. Kim J, Kim HS, Shim JJ, Lee J, Kim AY, Kim J. FEBS J; 2019 Nov 04; 286(22):4443-4472. PubMed ID: 31155838 [Abstract] [Full Text] [Related]
11. Mutation in the DNA-binding domain of the EWS-Oct-4 oncogene results in dominant negative activity that interferes with EWS-Oct-4-mediated transactivation. Kim S, Lee J, Kim JY, Lim B, Shin EK, Han YM, Kim SS, Song JH, Kim J. Int J Cancer; 2009 May 15; 124(10):2312-22. PubMed ID: 19170206 [Abstract] [Full Text] [Related]
12. Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells Results in EWS/FLI-1-dependent, ewing sarcoma-like tumors. Castillero-Trejo Y, Eliazer S, Xiang L, Richardson JA, Ilaria RL. Cancer Res; 2005 Oct 01; 65(19):8698-705. PubMed ID: 16204038 [Abstract] [Full Text] [Related]
13. The N-terminal domain of human TAFII68 displays transactivation and oncogenic properties. Bertolotti A, Bell B, Tora L. Oncogene; 1999 Dec 23; 18(56):8000-10. PubMed ID: 10637511 [Abstract] [Full Text] [Related]
14. A novel EWS-WT1 gene fusion product in desmoplastic small round cell tumor is a potent transactivator of the insulin-like growth factor-I receptor (IGF-IR) gene. Werner H, Idelman G, Rubinstein M, Pattee P, Nagalla SR, Roberts CT. Cancer Lett; 2007 Mar 08; 247(1):84-90. PubMed ID: 16730884 [Abstract] [Full Text] [Related]
15. GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance. Luo W, Gangwal K, Sankar S, Boucher KM, Thomas D, Lessnick SL. Oncogene; 2009 Nov 19; 28(46):4126-32. PubMed ID: 19718047 [Abstract] [Full Text] [Related]
16. Oncogenic EWS-Fli1 interacts with hsRPB7, a subunit of human RNA polymerase II. Petermann R, Mossier BM, Aryee DN, Khazak V, Golemis EA, Kovar H. Oncogene; 1998 Aug 06; 17(5):603-10. PubMed ID: 9704926 [Abstract] [Full Text] [Related]
17. A novel zinc finger gene is fused to EWS in small round cell tumor. Mastrangelo T, Modena P, Tornielli S, Bullrich F, Testi MA, Mezzelani A, Radice P, Azzarelli A, Pilotti S, Croce CM, Pierotti MA, Sozzi G. Oncogene; 2000 Aug 03; 19(33):3799-804. PubMed ID: 10949935 [Abstract] [Full Text] [Related]
18. EWS-FLI1 causes neuroepithelial defects and abrogates emigration of neural crest stem cells. Coles EG, Lawlor ER, Bronner-Fraser M. Stem Cells; 2008 Sep 03; 26(9):2237-44. PubMed ID: 18556509 [Abstract] [Full Text] [Related]
19. Malignant melanoma of the soft parts (clear-cell sarcoma): confirmation of EWS and ATF-1 gene fusion caused by a t(12;22) translocation. Speleman F, Delattre O, Peter M, Hauben E, Van Roy N, Van Marck E. Mod Pathol; 1997 May 03; 10(5):496-9. PubMed ID: 9160316 [Abstract] [Full Text] [Related]
20. EWSR1 is fused to POU5F1 in a bone tumor with translocation t(6;22)(p21;q12). Yamaguchi S, Yamazaki Y, Ishikawa Y, Kawaguchi N, Mukai H, Nakamura T. Genes Chromosomes Cancer; 2005 Jun 03; 43(2):217-22. PubMed ID: 15729702 [Abstract] [Full Text] [Related] Page: [Next] [New Search]